CPT1A and Hepatic fibrosis: Liver HSCs significantly enhance the activity of carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme in the β-oxidation of medium- and long-chain fatty acids, in both human and murine models of CCl4-induced and metabolism-driven liver fibrosis.